| Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China | |
| Liu, Danru; Sun, Jinqiao; Wang, Xiaochuan; Zhou, Qinhua; Ying, Wenjing; Sun, Bijun; Dong, Xiaolong; Wang, Wenjie; Hui, Xiaoying; Hou, Jia | |
| 刊名 | JOURNAL OF CLINICAL IMMUNOLOGY
 |
| 2019 | |
| 卷号 | 39期号:6 |
| 关键词 | Mycobacterium infection immunodeficiency IFN-gamma interleukin-12 receptor beta 1 subunit therapy |
| ISSN号 | 0271-9142 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3594706 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Liu, Danru,Sun, Jinqiao,Wang, Xiaochuan,et al. Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China[J]. JOURNAL OF CLINICAL IMMUNOLOGY,2019,39(6). |
| APA | Liu, Danru.,Sun, Jinqiao.,Wang, Xiaochuan.,Zhou, Qinhua.,Ying, Wenjing.,...&Yao, Haili.(2019).Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China.JOURNAL OF CLINICAL IMMUNOLOGY,39(6). |
| MLA | Liu, Danru,et al."Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China".JOURNAL OF CLINICAL IMMUNOLOGY 39.6(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论